Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome
GET TICKETS

Birner Dental Management Services, Inc. Announces Results For Fourth Quarter And Year Ended 2017

Share:

Birner Dental Management Services, Inc. Announces Results For Fourth Quarter And Year Ended 2017

- Revenue increased 3.1% in the fourth quarter of 2017

- Dentist count improved from 98 to 112 year over year

- Company strengthened its balance sheet with $5 million in Convertible Debt and Preferred Stock

PR Newswire

DENVER, April 2, 2018 /PRNewswire/ -- Birner Dental Management Services, Inc. (OTCQX:BDMS), business services provider of PERFECT TEETH® dental practices, announced results for the quarter and year ended December 31, 2017. 

For the quarter ended December 31, 2017 compared to the same period in 2016, revenue increased $437,000, or 3.1%, to $14.8 million.  The Company's Adjusted EBITDA decreased $348,000 to $(8,000) for the quarter ended December 31, 2017 compared to the same period in 2016.  Net loss for the quarter ended December 31, 2017 increased $427,000 to $(965,000) compared to $(539,000) for the same period of 2016.  Net loss per share increased to $(0.52) for the quarter ended December 31, 2017 compared to $(0.29) for the quarter ended December 31, 2016.  The earnings for the quarter ending December 31, 2017 were negatively affected by an increase in the allowance for doubtful accounts of $70,000 and an increase in the allowance  for customer service adjustments of $52,000.

For the year ended December 31, 2017 compared to 2016, revenue decreased $1.0 million, or 1.7%, to $60.7 million.  The Company's earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, and stock grant expense ("Adjusted EBITDA") decreased $1.6 million, or 65.7%, to $855,000 for the year ended December 31, 2017 compared to 2016.  Net loss for the year ended December 31, 2017 increased $1.3 million to $(2.6) million compared to $(1.4) million for the year ended December 31, 2016.  Loss per share increased to $(1.42) for the year ended December 31, 2017 compared to $(0.74) for the year ended December 31, 2016.  The Company incurred additional expenses of approximately $396,000 during the year ended December 31, 2017 in connection with matters related to an activist shareholder group and the Board of Directors' evaluation of the Company's strategic options that was discontinued in March 2017.

Revenue increased 3.1% in the fourth quarter of 2017 compared to the same quarter in 2016 after increasing 2.6% in the third quarter of 2017 compared to the same quarter in 2016.  The increase in revenue in each of the third and fourth quarters of 2017 over the same quarters in 2016 represents the first time in ten quarters that the Company has achieved consecutive quarterly year-over-year increases in revenue.  The Company believes these results are directly related to the Company increasing its dentist count as described below.

Additionally, the Company continues to experience strong patient flow with new patient visits up 9.8% in the fourth quarter of 2017 compared to  the fourth quarter of 2016 after normalizing for the number of working days in each respective quarter. On a similar basis, total patient visits were up 5.2% in the fourth quarter of 2017 compared to the fourth quarter of 2016.

While the Company was disappointed in the net loss generated in the fourth quarter and year ended December 31, 2017, the Company believes  most of the recent decline in revenue and Adjusted EBITDA has been driven by a lower dentist count. However,  the Company's dentist count has increased from 98 at December 31, 2016 to 112 at December  31, 2017. The Company believes it is beginning to achieve more stability among its dental professionals, but notes that the new additions have yet to achieve full capacity.

The Company has also continued its cost review process. Some of the actions taken include the reduction of executive officers' and outside directors' compensation, the negotiation of better terms with suppliers, and the consolidation of one money-losing location. Under the guidance of the reconstituted Board of Directors, the Company seeks to identify additional areas for cost improvements.

On December 28, 2017, following discussions and negotiations with Guaranty Bank and Trust Company (the "Bank") which is the lender under the Company's Loan and Security Agreement (the "Credit Facility"), and a number of potential investors and lenders, the  Company entered into a Security Purchase Agreement (the "Securities Purchase Agreement") and completed a private placement of $5 million of convertible senior subordinated secured notes (the "Notes") and 10 attached shares of Series A Convertible Preferred Stock with Palm Active Dental, LLC and Palm Global Small Cap Master Fund LP (the "Palm Investors"). The Company used approximately $2.6 million of the net proceeds under the Securities Purchase Agreement to repay the Bank as described below.  The balance of the net proceeds is being used for vendor payments, working capital, capital expenditures, and other general corporate purposes.  The Notes and attached shares of Series A Convertible Preferred Stock are convertible into shares of Series B Convertible Preferred Stock, which in turn are convertible into shares of the Company's common stock at a price of $5.00 per share.  Each share of Series A Preferred Stock entitles the holder to 100,000 votes per share. As a result of the investments by the Palm Investors, the Palm Investors beneficially own approximately 34.8% of the Company's common stock and have commensurate voting rights.

Also on December 28, 2017, the Company and the Bank entered into the Fifth Amendment to Loan and Security Agreement ("Fifth Amendment"), under which the Company repaid approximately $1.5 million under the term loan portion and $1.1 million under the revolving line of credit portion of the Credit Facility and the Bank waived all then-existing defaults, default interest, fees, and penalties under the Credit Facility. Among other things, the Fifth Amendment extends the maturity date of the loans under the Credit Facility to March 31, 2023, increases the availability to $2.0 million under the revolving line of credit and modifies the repayment terms of the term loan and the EBITDA, leverage ratio and other financial covenants under the Credit Facility.

In connection with the investment by the Palm Investors, two Palm representatives, Joshua S. Horowitz and Bradley Tirpak, were appointed to the Company's board of directors, replacing Brooks G. O'Neil and Dennis N. Genty, the Company's Chief Financial Officer, both of whom resigned from the board.

During the year ended December 31, 2017, the Company had capital expenditures of approximately $627,000, and decreased total bank debt by approximately $3.4 million including $2.6 million from the $5.0 million private placement completed December 28, 2017. The Company has recently contracted to upgrade three of its offices to digital radiography and plans to upgrade at least three more offices in the near future. The Company believes that this ongoing office modernization project is one of the keys to enhancing the Company's recruiting efforts and its patient's experience.

Birner Dental Management Services, Inc. acquires, develops, and manages geographically dense dental practice networks in select markets in Colorado, New Mexico, and Arizona.  As of December 31, 2017, the Company managed 68 dental offices under the PERFECT TEETH® name.

The Company previously announced it would conduct a conference call to review results for the year and quarter ended December 31, 2017 on Monday, April 2, 2018 at 9:00 a.m. MT.  In addition to current operating results, the teleconference may include discussion of management's expectations of future financial and operating results. To participate in this conference call, dial in to 1-888-312-9863 and refer to Confirmation Code 5742256 approximately five minutes prior to the scheduled time. If you are unable to join the conference call on April 2, 2018, the rebroadcast number is 1-888-203-1112 with the pass code of 5742256.  This rebroadcast will be available through April 16, 2018.

Non-GAAP Disclosures

This press release includes a non-GAAP financial measure with respect to Adjusted EBITDA.  Please see below for more information regarding Adjusted EBITDA and a reconciliation of Adjusted EBITDA to net loss.

Forward-Looking Statements

Certain of the matters discussed herein may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from expectations. These include statements of belief regarding the Company's prospects and performance in future periods, including the impact of dentist recruitment, turnover and dentist count and office upgrades.  These statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.  These and other risks and uncertainties are set forth in the reports filed by the Company with the Securities and Exchange Commission. The Company disclaims any obligation to update these forward-looking statements.

For Further Information Contact:
Birner Dental Management Services, Inc.
Dennis Genty  
Chief Financial Officer
(303) 691-0680

BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES


CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS




Quarters Ended


Years Ended




December 31,


December 31,




2016


2017


2016


2017


REVENUE:










Dental practice revenue

$ 13,158,048


$ 13,732,425


$ 57,167,491


$ 56,647,595



Capitation revenue

1,133,585


996,093


4,594,803


4,064,809




14,291,633


14,728,518


61,762,294


60,712,404












DIRECT EXPENSES:










Clinical salaries and benefits

8,638,093


9,123,033


37,202,203


37,521,910



Dental supplies

633,233


666,074


2,820,462


2,641,069



Laboratory fees

840,567


913,539


3,489,225


3,600,542



Occupancy

1,566,735


1,568,387


6,279,180


6,409,158



Advertising and marketing

168,260


134,015


658,487


619,642



Depreciation and amortization

967,136


825,901


3,993,299


3,573,983



General and administrative

1,338,422


1,470,000


5,477,903


5,484,758




14,152,446


14,700,949


59,920,759


59,851,062













Contribution from dental offices

139,187


27,569


1,841,535


861,342












CORPORATE EXPENSES:










General and administrative 

820,535

(1)

970,983

(1)

3,516,657

(2)

3,850,624

(2)


Stock grant

-


-


-


175,000

(3)


Depreciation and amortization

44,820


37,768


210,813


161,235












OPERATING LOSS

(726,168)


(981,182)


(1,885,935)


(3,325,517)


OTHER EXPENSE:










Interest expense, net

68,700


166,798


253,940


443,640












LOSS BEFORE INCOME TAXES

(794,868)


(1,147,980)


(2,139,875)


(3,769,157)



Income tax benefit

(256,321)


(182,645)


(753,973)


(1,119,926)












NET LOSS

$    (538,547)


$    (965,335)


$ (1,385,902)


$ (2,649,231)













Net loss per share of Common Stock - Basic

$          (0.29)


$          (0.52)


$          (0.74)


$          (1.42)













Net loss per share of Common Stock - Diluted

$          (0.29)


$          (0.52)


$          (0.74)


$          (1.42)













Weighted average number of shares of Common Stock and dilutive securities:










Basic

1,860,261


1,872,761


1,860,316


1,868,138













Diluted

1,860,261


1,872,761


1,860,316


1,868,138














(1)

Corporate expense - general and administrative includes $54,560 and $109,922 of stock-based compensation expense pursuant to ASC Topic 718 for the quarters ended December 31, 2016 and 2017, respectively.



(2)

Corporate expense - general and administrative includes $177,679and $270,207 of stock-based compensation expense pursuant to ASC Topic 718 for the year ended December 31, 2016 and 2017, respectively.



(3)

The Company issued 12,500 shares of Common Stock under a settlement agreement with an activist shareholder group. The shares were valued at $175,000 based on the closing price of the Common Stock on the date of the grant.

 

BIRNER DENTAL MANAGEMENT SERVICES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS








December 31, 

ASSETS

2016


2017

CURRENT ASSETS:





Cash

$      157,923


$          1,888,828


Accounts receivable, net of allowance for doubtful accounts of approximately $410,000 and $500,000, respectively

3,212,190


3,772,514


Note receivable

34,195


33,768


Prepaid expenses and other assets

759,749


655,310







Total current assets

4,164,057


6,350,420






PROPERTY AND EQUIPMENT, net

7,279,436


5,016,141






OTHER NONCURRENT ASSETS:





Intangible assets, net

6,721,084


5,876,053


Deferred charges and other assets

155,741


163,991


Note receivable

31,051


-







Total assets

$ 18,351,369


$        17,406,605






LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)









CURRENT LIABILITIES:





Accounts payable 

$   2,723,473


$          4,210,521


Accrued expenses

925,776


777,863


Accrued payroll and related expenses

2,164,758


2,009,720


Current maturities of long-term debt

2,500,000


750,000







Total current liabilities

8,314,007


7,748,104






LONG-TERM LIABILITIES:





Deferred tax liability, net

1,174,416


101,482


Bank credit facility, net

7,351,006


5,684,085


Convertible senior subordinated secured notes, net

-


4,445,862


Other long-term obligations

1,081,655


1,190,811







Total liabilities

17,921,084


19,170,344






COMMITMENTS AND CONTINGENCIES 






SERIES A PREFERRED STOCK, no par value, 100 shares authorized, 10 shares outstanding

-


10,000

SERIES B PREFERRED STOCK, no par value, 2,000,000 shares authorized, none outstanding

-


-






SHAREHOLDERS' EQUITY / (DEFICIT):





Preferred Stock, no par value, 7,999,900 shares authorized; none outstanding

-


-


Common Stock, no par value, 20,000,000 shares authorized; 1,860,261 and 1,872,761 shares issued and outstanding, respectively

1,615,001


2,060,208


Accumulated deficit

(1,184,716)


(3,833,947)







Total shareholders' equity (deficit)

430,285


(1,773,739)







Total liabilities and shareholders' equity (deficit)

$ 18,351,369


$        17,406,605

Reconciliation of Adjusted EBITDA

Adjusted EBITDA is not a U.S. generally accepted accounting principle ("GAAP") measure of performance or liquidity. However, the Company believes that it may be useful to an investor in evaluating the Company's ability to meet future debt service, capital expenditures and working capital requirements, and the Company uses Adjusted EBITDA for this purpose.  Investors should not consider Adjusted EBITDA in isolation or as a substitute for operating income, cash flows from operating activities or any other measure for determining the Company's operating performance or liquidity that is calculated in accordance with GAAP. In addition, because Adjusted EBITDA is not calculated in accordance with GAAP, it may not necessarily be comparable to similarly titled measures employed by other companies. A reconciliation of Adjusted EBITDA to net loss can be made by adding depreciation and amortization expense - Offices, depreciation and amortization expense – Corporate, stock-based compensation expense, interest expense, net, stock grant expense and income tax (benefit) to net loss as in the table below.




Quarters


Years 




Ended December 31,


Ended December 31,




2016


2017


2016


2017

RECONCILIATION OF ADJUSTED EBITDA:









Net loss

($538,547)


($965,335)


($1,385,902)


($2,649,231)


Add back:










Depreciation and amortization - Offices

967,136


825,901


3,993,299


3,573,983



Depreciation and amortization - Corporate

44,820


37,768


210,813


161,235



Stock-based compensation expense

54,560


109,922


177,679


270,207



Interest expense, net

68,700


166,798


253,940


443,640



Stock grant expense

-


0


-


175,000



Income tax benefit

(256,321)


(182,645)


(753,973)


(1,119,926)











Adjusted EBITDA

$340,348


(7,591)


$2,495,856


$854,908

 

Cision View original content:http://www.prnewswire.com/news-releases/birner-dental-management-services-inc-announces-results-for-fourth-quarter-and-year-ended-2017-300622322.html

SOURCE Birner Dental Management Services, Inc.

View Comments and Join the Discussion!